Dr. Zuzana Tothova is an Assistant Professor of Medicine at Harvard Medical School (HMS), the Edward P. Evans Investigator in the Department of Medical Oncology at the Dana-Farber Cancer Institute (DFCI), and Associate Member of the Broad Institute. She received her B.A. in Biology and Chemistry from Williams College, a doctorate in Genetics from Harvard University, an M.D. from HMS/MIT in the Health Sciences and Technology program and completed residency, fellowship and postdoctoral training in internal medicine, adult hematology and oncology and epigenetics at the Brigham and Women's Hospital, DFCI and the Broad Institute. Since establishing her independent laboratory at DFCI in 2018, her research program has focused on cancer epigenetics and basic mechanistic and translational investigation of chromatin regulation during blood cancer development, with the ultimate goal of intercepting progression from clonal hematopoiesis to MDS and AML development.